These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15025423)

  • 1. Platelet serotonin 5-HT2A receptor binding in patients with carcinoid tumor.
    Spigset O; Kristoffersson A; Mjörndal T
    Scand J Clin Lab Invest; 2004; 64(1):3-8. PubMed ID: 15025423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary serotonin in the diagnosis of carcinoid tumors.
    Feldman JM
    Clin Chem; 1986 May; 32(5):840-4. PubMed ID: 2421946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circannual variations in the binding of [3H]lysergic acid diethylamide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers.
    Spigset O; Allard P; Mjörndal T
    Biol Psychiatry; 1998 May; 43(10):774-80. PubMed ID: 9606533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fluvoxamine on platelet 5-HT2A receptors as studied by [3H]lysergic acid diethylamide ([3H]LSD) binding in healthy volunteers.
    Spigset O; Mjörndal T
    Psychopharmacology (Berl); 1997 Sep; 133(1):39-42. PubMed ID: 9335078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved diagnosis of carcinoid tumors by measurement of platelet serotonin.
    Kema IP; de Vries EG; Schellings AM; Postmus PE; Muskiet FA
    Clin Chem; 1992 Apr; 38(4):534-40. PubMed ID: 1373675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminating capacity of indole markers in the diagnosis of carcinoid tumors.
    Meijer WG; Kema IP; Volmer M; Willemse PH; de Vries EG
    Clin Chem; 2000 Oct; 46(10):1588-96. PubMed ID: 11017936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet serotonin 5-HT2A receptor binding in patients with carcinoid tumor.
    Stenman UH
    Scand J Clin Lab Invest; 2004; 64(1):1-2. PubMed ID: 15025422
    [No Abstract]   [Full Text] [Related]  

  • 8. Serotonin 5-HT2A receptor binding in platelets from healthy subjects as studied by [3H]-lysergic acid diethylamide ([3H]-LSD): intra- and interindividual variability.
    Spigset O; Mjörndal T
    Neuropsychopharmacology; 1997 Apr; 16(4):285-93. PubMed ID: 9094146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced platelet serotonin 5-HT2A receptor binding in anorexia nervosa and bulimia nervosa.
    Spigset O; Andersen T; Hägg S; Mjöndal T
    Eur Neuropsychopharmacol; 1999 Dec; 9(6):469-73. PubMed ID: 10625113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of menstrual cycle on platelet serotonin uptake site and serotonin2A receptor binding.
    Wihlbäck AC; Sundström Poromaa I; Bixo M; Allard P; Mjörndal T; Spigset O
    Psychoneuroendocrinology; 2004 Jul; 29(6):757-66. PubMed ID: 15110925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin, catecholamines, histamine, and their metabolites in urine, platelets, and tumor tissue of patients with carcinoid tumors.
    Kema IP; de Vries EG; Slooff MJ; Biesma B; Muskiet FA
    Clin Chem; 1994 Jan; 40(1):86-95. PubMed ID: 7507008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with carcinoid syndrome exhibit symptoms of aggressive impulse dysregulation.
    Russo S; Boon JC; Kema IP; Willemse PH; den Boer JA; Korf J; de Vries EG
    Psychosom Med; 2004; 66(3):422-5. PubMed ID: 15184706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of whole blood serotonin and plasma and urine 5-hydroxyindole acetic acid in diagnosis of carcinoid disease.
    Carling RS; Degg TJ; Allen KR; Bax ND; Barth JH
    Ann Clin Biochem; 2002 Nov; 39(Pt 6):577-82. PubMed ID: 12564839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between central and peripheral serotonin 5-HT2A receptors: a positron emission tomography study in healthy individuals.
    Cho R; Kapur S; Du L; Hrdina P
    Neurosci Lett; 1999 Feb; 261(3):139-42. PubMed ID: 10081968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal function in the carcinoid syndrome: effects of the serotonin antagonist cyproheptadine.
    Plank J; Feldman JM
    Metabolism; 1975 Sep; 24(9):1035-46. PubMed ID: 1171350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes.
    Geaney DP; Schächter M; Elliot JM; Grahame-Smith DG
    Eur J Pharmacol; 1984 Jan; 97(1-2):87-93. PubMed ID: 6698111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of postmenopausal hormone replacement therapy on platelet serotonin uptake site and serotonin 2A receptor binding.
    Wihlbäck AC; Sundström-Poromaa I; Allard P; Mjörndal T; Spigset O; Bäckström T
    Obstet Gynecol; 2001 Sep; 98(3):450-7. PubMed ID: 11530128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase of urinary 5-hydroxyindoleacetic acid excretion but not serum chromogranin A following over-the-counter 5-hydroxytryptophan intake.
    Joy T; Walsh G; Tokmakejian S; Van Uum SH
    Can J Gastroenterol; 2008 Jan; 22(1):49-53. PubMed ID: 18209781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
    Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
    Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling of tryptophan-related plasma indoles in patients with carcinoid tumors by automated, on-line, solid-phase extraction and HPLC with fluorescence detection.
    Kema IP; Meijer WG; Meiborg G; Ooms B; Willemse PH; de Vries EG
    Clin Chem; 2001 Oct; 47(10):1811-20. PubMed ID: 11568091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.